These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
753 related articles for article (PubMed ID: 26673543)
1. The peroxisome proliferator-activated receptor γ agonist pioglitazone prevents NF-κB activation in cisplatin nephrotoxicity through the reduction of p65 acetylation via the AMPK-SIRT1/p300 pathway. Zhang J; Zhang Y; Xiao F; Liu Y; Wang J; Gao H; Rong S; Yao Y; Li J; Xu G Biochem Pharmacol; 2016 Feb; 101():100-11. PubMed ID: 26673543 [TBL] [Abstract][Full Text] [Related]
2. The peroxisome proliferator-activated receptor β/δ (PPARβ/δ) agonist GW501516 prevents TNF-α-induced NF-κB activation in human HaCaT cells by reducing p65 acetylation through AMPK and SIRT1. Barroso E; Eyre E; Palomer X; Vázquez-Carrera M Biochem Pharmacol; 2011 Feb; 81(4):534-43. PubMed ID: 21146504 [TBL] [Abstract][Full Text] [Related]
3. SIRT1 overexpression decreases cisplatin-induced acetylation of NF-κB p65 subunit and cytotoxicity in renal proximal tubule cells. Jung YJ; Lee JE; Lee AS; Kang KP; Lee S; Park SK; Lee SY; Han MK; Kim DH; Kim W Biochem Biophys Res Commun; 2012 Mar; 419(2):206-10. PubMed ID: 22330808 [TBL] [Abstract][Full Text] [Related]
4. Rosiglitazone ameliorates cisplatin-induced renal injury in mice. Lee S; Kim W; Moon SO; Sung MJ; Kim DH; Kang KP; Jang YB; Lee JE; Jang KY; Park SK Nephrol Dial Transplant; 2006 Aug; 21(8):2096-105. PubMed ID: 16728429 [TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effects of pioglitazone in a rat model of permanent focal cerebral ischemia are associated with peroxisome proliferator-activated receptor gamma-mediated suppression of nuclear factor-κB signaling pathway. Zhang HL; Xu M; Wei C; Qin AP; Liu CF; Hong LZ; Zhao XY; Liu J; Qin ZH Neuroscience; 2011 Mar; 176():381-95. PubMed ID: 21185913 [TBL] [Abstract][Full Text] [Related]
6. The peroxisome proliferator-activated receptor-γ agonist pioglitazone protects against cisplatin-induced renal damage in mice. Jesse CR; Bortolatto CF; Wilhelm EA; Roman SS; Prigol M; Nogueira CW J Appl Toxicol; 2014 Jan; 34(1):25-32. PubMed ID: 22987311 [TBL] [Abstract][Full Text] [Related]
7. Protection of resveratrol on acute kidney injury in septic rats. Gan Y; Tao S; Cao D; Xie H; Zeng Q Hum Exp Toxicol; 2017 Oct; 36(10):1015-1022. PubMed ID: 27837177 [TBL] [Abstract][Full Text] [Related]
8. Additive Renoprotection by Pioglitazone and Fenofibrate against Inflammatory, Oxidative and Apoptotic Manifestations of Cisplatin Nephrotoxicity: Modulation by PPARs. Helmy MM; Helmy MW; El-Mas MM PLoS One; 2015; 10(11):e0142303. PubMed ID: 26536032 [TBL] [Abstract][Full Text] [Related]
10. Rosiglitazone, a Peroxisome Proliferator-Activated Receptor (PPAR)-γ Agonist, Attenuates Inflammation Via NF-κB Inhibition in Lipopolysaccharide-Induced Peritonitis. Zhang YF; Zou XL; Wu J; Yu XQ; Yang X Inflammation; 2015 Dec; 38(6):2105-15. PubMed ID: 26047949 [TBL] [Abstract][Full Text] [Related]
11. Crosstalk between peroxisome proliferator-activated receptor-γ and mineralcorticoid receptor in TNF-α activated renal tubular cell. Xiao J; Chen W; Lu Y; Zhang X; Fu C; Yan Z; Zhang Z; Ye Z Inflamm Res; 2015 Aug; 64(8):603-14. PubMed ID: 26072064 [TBL] [Abstract][Full Text] [Related]
12. Resveratrol attenuates ICAM-1 expression and monocyte adhesiveness to TNF-α-treated endothelial cells: evidence for an anti-inflammatory cascade mediated by the miR-221/222/AMPK/p38/NF-κB pathway. Liu CW; Sung HC; Lin SR; Wu CW; Lee CW; Lee IT; Yang YF; Yu IS; Lin SW; Chiang MH; Liang CJ; Chen YL Sci Rep; 2017 Mar; 7():44689. PubMed ID: 28338009 [TBL] [Abstract][Full Text] [Related]
13. Silibinin-induced autophagy mediated by PPARα-sirt1-AMPK pathway participated in the regulation of type I collagen-enhanced migration in murine 3T3-L1 preadipocytes. Liu X; Xu Q; Long X; Liu W; Zhao Y; Hayashi T; Hattori S; Fujisaki H; Ogura T; Tashiro SI; Onodera S; Yamato M; Ikejima T Mol Cell Biochem; 2019 Jan; 450(1-2):1-23. PubMed ID: 29916120 [TBL] [Abstract][Full Text] [Related]
14. Endothelial PPAR-γ provides vascular protection from IL-1β-induced oxidative stress. Mukohda M; Stump M; Ketsawatsomkron P; Hu C; Quelle FW; Sigmund CD Am J Physiol Heart Circ Physiol; 2016 Jan; 310(1):H39-48. PubMed ID: 26566726 [TBL] [Abstract][Full Text] [Related]
15. Involvement of glucocorticoid receptor and peroxisome proliferator activated receptor-gamma in pioglitazone mediated chronic gastric ulcer healing in rats. Lahiri S; Sen T; Palit G Eur J Pharmacol; 2009 May; 609(1-3):118-25. PubMed ID: 19281808 [TBL] [Abstract][Full Text] [Related]
16. G Protein-coupled Receptor 40 (GPR40) and Peroxisome Proliferator-activated Receptor γ (PPARγ): AN INTEGRATED TWO-RECEPTOR SIGNALING PATHWAY. Wang S; Awad KS; Elinoff JM; Dougherty EJ; Ferreyra GA; Wang JY; Cai R; Sun J; Ptasinska A; Danner RL J Biol Chem; 2015 Aug; 290(32):19544-57. PubMed ID: 26105050 [TBL] [Abstract][Full Text] [Related]
17. Baicalein, a Bioflavonoid, Prevents Cisplatin-Induced Acute Kidney Injury by Up-Regulating Antioxidant Defenses and Down-Regulating the MAPKs and NF-κB Pathways. Sahu BD; Mahesh Kumar J; Sistla R PLoS One; 2015; 10(7):e0134139. PubMed ID: 26222683 [TBL] [Abstract][Full Text] [Related]
18. Antagonistic crosstalk between NF-κB and SIRT1 in the regulation of inflammation and metabolic disorders. Kauppinen A; Suuronen T; Ojala J; Kaarniranta K; Salminen A Cell Signal; 2013 Oct; 25(10):1939-48. PubMed ID: 23770291 [TBL] [Abstract][Full Text] [Related]
19. Activation of peroxisome proliferator-activated receptor-gamma protects pancreatic beta-cells from cytokine-induced cytotoxicity via NF kappaB pathway. Kim EK; Kwon KB; Koo BS; Han MJ; Song MY; Song EK; Han MK; Park JW; Ryu DG; Park BH Int J Biochem Cell Biol; 2007; 39(6):1260-75. PubMed ID: 17521952 [TBL] [Abstract][Full Text] [Related]
20. Resveratrol prevents renal lipotoxicity and inhibits mesangial cell glucotoxicity in a manner dependent on the AMPK-SIRT1-PGC1α axis in db/db mice. Kim MY; Lim JH; Youn HH; Hong YA; Yang KS; Park HS; Chung S; Ko SH; Shin SJ; Choi BS; Kim HW; Kim YS; Lee JH; Chang YS; Park CW Diabetologia; 2013 Jan; 56(1):204-17. PubMed ID: 23090186 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]